Putting Ireland at the forefront of medicine development for children
Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
US drug giant Gilead opens child medicine centre of excellence in Dublin
Docklands site will run clinical trials for paediatric versions of current and future drugs
‘Alexa, analyse my bowel movement’: Will we all soon have smart toilets?
High-tech loos could help monitor our health – but also share our private information
Rohan Holdings secures latest tenant at North City Business Park
Developer pre-lets 25,000sq ft warehouse to US pharma giant Bio-Techne Corporation
The Handmaid’s Tale, once an urgent parable for our times, has become merely adequate
Season 4 review: Elisabeth Moss is the best thing about an only occasionally gripping series
Will patent waiver really deliver Covid vaccine worldwide?
Cantillon: Balancing costs of research and needs of poorer countries is a challenge
Rohan secures Thermo Fisher Scientific for Dublin Airport Logistics Park
US life sciences giant signs up for 51,288sq ft Crane House in advance of Q4 completion
Virus fears hit European shares as UK stocks rise on reopening hopes
Iseq moves into positive territory on upbeat corporate news
Patrick Freyne: Pooing in a bucket? That’s the whole point of the show
A more apt title for new reality show Don’t Rock the Boat would be Celebrity S**t in a Bucket
Cork-based industrial energy company EM3 taken over by Calor owner
SHV Energy acquires majority stake in Charleville-headquartered company
Remdesivir has little effect on Covid-19 mortality, WHO study says
Significant blow to hopes of identifying existing medicines to treat disease
No remdesivir shortage in Ireland, HSE says as concern grows for Europe’s supply
Acute shortages reported in number of countries because of difficulties with stocks from US
Coronavirus: Dutch hospitals run out of remdesivir anti-viral treatment
Situation causes concerns that this could indicate start of Europe-wide shortage
Trump treatment includes experimental drug from firm with a Limerick factory
President was granted access to REGN-COV2 following a compassionate-use request
LVMH’s refusal to put a ring on Tiffany fails to dent merger flurry
Market Beat: With M&A activity busy, competition authorities need to be on their toes
Rohan Holdings begins delivery of 165,000sq of logistics space along M50
Speculative development follows 250,000sq ft of letting activity within the past 12 months
Coronavirus: Australia reports record single day rise in deaths
World round-up: China reports new infections as Greece announces record daily number of cases
Coronavirus: European Union signs Remdesivir deal with Gilead
€63m contract covers 30,000 patients with severe Covid-19 symptoms in Europe
Upbeat economic data helps European markets snap three-day losing run
Dublin closes higher as banks bounce back and CRH, Ryanair and Dalata all gain
Gilead to add 140 jobs in Ireland as it plans new Dublin base
Company to invest €7m as it also establishes paediatric centre of excellence here
DHL boss Frank Appel: ‘We’ll be back to normal sooner than people think’
The world would be a worse place without globalisation, says the 58-year-old German
Irish pharma sector warns of protectionism as US corners supply
Alert comes after US secures Covid-19 drug treatment for next three months
WHO stops hydroxychloroquine trials for hospitalised Covid-19 patients
UN agency ends treatment after results show little or no reduction in mortality
Q&A: How close are we to having a Covid-19 vaccine?
Scale of scientific endeavour is unprecedented with more than 145 candidates in development
World takes stock of Covid-19 drug after US snaps up supplies
Fears of shortages after maker of remdesivir pledges most output to US for next three months
Coronavirus: Vaccine scepticism in US may scupper immunity, says Fauci
Immunologist says US may struggle to achieve herd immunity even if a vaccine is developed due to prevailing scepticism
Gilead’s remdesivir endorsed as first treatment for Covid-19 in Europe
EMA committee recommends drug’s use in adults and adolescents from 12 years of age
Coronavirus: Fauci calls for action to prevent ‘surge’ in US
Warning as Texas, Florida and Arizona all report biggest one-day increases in cases
AstraZeneca and Gilead explore possibility of merger
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
EU may fast-track sale of drug remdesivir as treatment for Covid-19
Approval would allow sale of drug in bloc for one year before all data on effects known
Rigorous science rather than speed matters most in race for a Covid-19 cure
On a potential vaccine: ‘the air is thick with absurd promissory notes and dates of delivery’
Stocktake: Stock markets chase hints of post-coronavirus recovery
Stocks soar on promising news remdesivir an effective treatment for virus
Gilead drug to be given to Covid-19 patients this week
Drugs company has about 50,000 courses of remdesivir ready to distribute in the US
US economy shrinks by 4.8% with worse to come, warn experts
Contraction in GDP between January and March exceeded most analysts’ expectations
US Congress poised to back $480bn Covid-19 rescue package
Governors slam Senate leader McConnell over ‘irresponsible’ state bankruptcy comments
Gilead antiviral drug remdesivir flops in first trial
Disappointing results revealed in draft documents published accidentally by WHO
Stocks rally on hopes for Covid-19 treatment
Iseq outperforms European peers and rises 3.83%, with Flutter a standout performer
Gilead’s coronavirus drug: why experts are cautious on its prospects
US shares rise after leaked report enthused about benefits of remdesivir in 125 Covid-19 patients
Gilead drug boosts investor hopes for coronavirus treatment
Early impressions from US study show severely ill patients in clinical trial recovering quickly
Coronavirus – the science: The case for crushing Covid-19 rather than living with it
Edition 5: Why has virus spread in Ireland been discernibly different to the UK?
Coronavirus: The drug options come into sharp focus
Right now, remdesivir is the most promising one in tackling the virus head-on
Coronavirus: The good news and the good news to be wary of
Here amid the gloom are some positive developments. However, there are caveats
Prospect of interest rate cuts helps global markets recover
Markets report: Iseq was virtually flat on the day with Ryanair amongst losers
Coronavirus: reinfection discovery may be blow to vaccine hopes
Pharmaceutical company Gilead is working on a drug that is in human trial stage
Patrick Freyne on Love Is Blind: It’s Gilead, Love Island and Blind Date rolled into one
Netflix’s dystopian dating show asks if it’s what’s inside that really counts (Spoiler: it isn’t)
Geodis Ireland takes 185,000sq ft at Dublin Airport Logistics Park
Iput secures initial rent of €1.6m per annum on 20-year lease of former Eason warehouse
Gilead accused of breaching Irish patent for HIV drug
ViiV Healthcare Company and Shionogi & Co are suing Gilead and its Irish subsidiary
Sandyford Business District defines success of suburban office market
South Dublin proving to be an increasingly attractive alternative for global tech giants
Are Church of Ireland bishops about to fail their vast middle ground?
The General Synod and not Gafcon decides the policy and doctrine of the Church of Ireland
Lake Like a Mirror: Surreal but real stories of women in Malaysia
Book review: Ho Sok Fong has written an inventive, troubling second collection
US sues Gilead over HIV patent infringements
Lawsuit claims drugmaker reaped billions of dollars through taxpayer-funded research
Margaret Atwood says Ireland is a ‘little point of light’ globally
Booker Prize winning author puts hope in young people in battle against totalitarianism
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices